HomePLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
$1.81
After Hours:(1.10%)+0.020
$1.83
Closed: Sep 12, 6:50:57 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$1.74
Day range
$1.73 - $1.85
Year range
$0.99 - $3.10
Market cap
144.32M USD
Avg Volume
619.31K
P/E ratio
31.83
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 15.66M | 16.21% |
Operating expense | 8.62M | 33.69% |
Net income | 164.00K | 107.44% |
Net profit margin | 1.05 | 106.42% |
Earnings per share | — | — |
EBITDA | 1.53M | 172.68% |
Effective tax rate | 75.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.40M | -25.83% |
Total assets | 78.49M | -14.26% |
Total liabilities | 28.58M | -54.60% |
Total equity | 49.90M | — |
Shares outstanding | 79.73M | — |
Price to book | 2.76 | — |
Return on assets | 3.85% | — |
Return on capital | 5.54% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 164.00K | 107.44% |
Cash from operations | -5.23M | -44.96% |
Cash from investing | -438.00K | -143.33% |
Cash from financing | 4.10M | — |
Net change in cash | -1.56M | 58.98% |
Free cash flow | -6.42M | -65.80% |
About
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Founded
1993
Headquarters
Website
Employees
213
